Literature DB >> 24954667

Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma.

Zhaoyang Liu1, Kangsheng Tu2, Qingguang Liu3.   

Abstract

The role of microRNA-30a (miR-30a) deregulation in tumor progression and its downstream signaling pathways remain unknown. Here we confirmed significant downregulation of miR-30a in hepatocellular carcinoma (HCC) tissues and cell lines compared with non-tumor counterparts. MiR-30a downregulation was significantly associated with worse disease-free survival (DFS) of HCC patients. Gain- and loss-of-function studies revealed that downregulation of miR-30a facilitated tumor cell migration, invasion and epithelial-mesenchymal transition (EMT). We identified SNAI1 as a direct target of miR-30a and demonstrated miR-30a as a novel regulator of EMT by targeting SNAI1, indicating its potential therapeutic value for reducing invasion and metastasis of HCC.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  EMT; HCC; MicroRNA-30a; SNAI1

Mesh:

Substances:

Year:  2014        PMID: 24954667     DOI: 10.1016/j.febslet.2014.06.037

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  31 in total

1.  Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis.

Authors:  Zhengqiang Wang; Qianshan Ding; Yanxia Li; Qingqing Liu; Wei Wu; Lu Wu; Honggang Yu
Journal:  Tumour Biol       Date:  2016-09-16

2.  MiR-511 inhibits growth and metastasis of human hepatocellular carcinoma cells by targeting PIK3R3.

Authors:  Gang Cao; Weihua Dong; Xiaoxi Meng; Hongchao Liu; Huaqiang Liao; Shiyuan Liu
Journal:  Tumour Biol       Date:  2015-01-22

3.  MiR-30a-5p suppresses cell growth and enhances apoptosis of hepatocellular carcinoma cells via targeting AEG-1.

Authors:  Rongquan He; Lihua Yang; Xiaomiao Lin; Xin Chen; Xinggu Lin; Fanglin Wei; Xiaona Liang; Yihuan Luo; Yuzhuang Wu; Tingqing Gan; Yiwu Dang; Gang Chen
Journal:  Int J Clin Exp Pathol       Date:  2015-12-01

4.  Long noncoding RNA CNALPTC1 promotes cell proliferation and migration of papillary thyroid cancer via sponging miR-30 family.

Authors:  Cunrong Chen; Lili Zhou; Hui Wang; Junnian Chen; Wen Li; Wei Liu; Mingjie Shen; Hongzhou Liu; Xiaomin Fu
Journal:  Am J Cancer Res       Date:  2018-01-01       Impact factor: 6.166

5.  MicroRNA-30a as a candidate underlying sex-specific differences in neonatal hyperoxic lung injury: implications for BPD.

Authors:  Yuhao Zhang; Cristian Coarfa; Xiaoyu Dong; Weiwu Jiang; Brielle Hayward-Piatkovskyi; Jason P Gleghorn; Krithika Lingappan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-01       Impact factor: 5.464

6.  Absent expression of miR-30a promotes the growth of lung cancer cells by targeting MEF2D.

Authors:  Nianxu Luan; Yi Wang; Xuedong Liu
Journal:  Oncol Lett       Date:  2018-05-16       Impact factor: 2.967

Review 7.  Regulation of cancer metastasis by microRNAs.

Authors:  Shih-Hsuan Chan; Lu-Hai Wang
Journal:  J Biomed Sci       Date:  2015-01-23       Impact factor: 8.410

8.  microRNA-497 inhibits cell proliferation and induces apoptosis by targeting YAP1 in human hepatocellular carcinoma.

Authors:  Lei Zhang; Zhaoxiang Yu; Yao Xian; Xiaobo Lin
Journal:  FEBS Open Bio       Date:  2016-02-01       Impact factor: 2.693

9.  DDR2 facilitates hepatocellular carcinoma invasion and metastasis via activating ERK signaling and stabilizing SNAIL1.

Authors:  Binhui Xie; Weihao Lin; Junming Ye; Xiaonong Wang; Bing Zhang; Shiqiu Xiong; Heping Li; Guosheng Tan
Journal:  J Exp Clin Cancer Res       Date:  2015-09-11

10.  MicroRNA-212 inhibits hepatocellular carcinoma cell proliferation and induces apoptosis by targeting FOXA1.

Authors:  Huahua Tu; Gang Wei; Qinghe Cai; Xianxiang Chen; Zequn Sun; Caitao Cheng; Linfei Zhang; Yong Feng; Huadong Zhou; Bo Zhou; Tiancai Zeng
Journal:  Onco Targets Ther       Date:  2015-08-24       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.